Advanced search
Publication Cover
Research and Reports in Tropical Medicine Volume 14, 2023 - Issue
Submit an article Journal homepage
116
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Lack of Suspicion of Dapsone Hypersensitivity Syndrome in a Leprosy Patient: Case Report with Fatal Outcome

Ruth Ansah1 Center of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyORCID Iconhttps://orcid.org/0009-0001-8374-2290
ORCID Icon,
Ebenezer Ameyaw Arkoh2 Ankaful Leprosy / General Hospital, Ankaful, Central Region, GhanaORCID Iconhttps://orcid.org/0009-0008-8423-8775
ORCID Icon,
Benedict Okoe Quao2 Ankaful Leprosy / General Hospital, Ankaful, Central Region, Ghana;3 National Leprosy Control Program, Ghana Health Service, Accra, Ghana
&
Mirjam Groger1 Center of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine and I. Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyCorrespondence[email protected]
Pages 135-139 | Received 05 Oct 2023, Accepted 06 Dec 2023, Published online: 28 Dec 2023

References

  • Barr J. A short history of dapsone, or an alternative model of drug development. J Hist Med Allied Sci. 2011;66(4):425–467. doi:10.1093/jhmas/jrq068
  • Dal Secco RGC, França K, Castillo D, et al. A synopsis of the history of Hansen’s disease. Wien Med Wochenschr. 2017;167:27–30. doi:10.1007/s10354-017-0590-2
  • Lorenz M, Wozel G, Schmitt J. Hypersensitivity reactions to dapsone: a systematic review. Acta Derm Venereol. 2012;92(2):194–199. doi:10.2340/00015555-1268
  • Tortelly VD, Daxbacher EL, Brotas AM, Carneiro S. Adverse effects of polychemotherapy for leprosy in 13 years of follow-up at a university hospital. An Bras Dermatol. 2021;96:224–227. doi:10.1016/j.abd.2020.07.005
  • Wang N, Parimi L, Liu H, Zhang F. A review on dapsone hypersensitivity syndrome among Chinese patients with an emphasis on preventing adverse drug reactions with genetic testing. Am J Trop Med Hyg. 2017;96(5):1014–1018. PMC5417189. doi:10.4269/ajtmh.16-0628
  • Rao PN, Lakshmi TS. Increase in the incidence of dapsone hypersensitivity syndrome--an appraisal. Lepr Rev. 2001;72(1):57–62. doi:10.5935/0305-7518.20010009
  • Richardus JH, Smith TC. Increased incidence in leprosy of hypersensitivity reactions to dapsone after introduction of multidrug therapy. Lepr Rev. 1989;60(4):267–273. doi:10.5935/0305-7518.19890033
  • Serea RVP, de Paula CDR, Do Prado MRM, Laudelino ACF, de Freitas ACG. Aspectos clínicos e laboratoriais da síndrome sulfona: a propósito de um caso [Clinical and laboratory aspects of sulfone syndrome: a case report]. Braz J Dev. 2020;6(8):62536–62544. Portuguese. doi:10.34117/bjdv6n8-622
  • Kumari RT, Dependra KT, Devinder M. Drug hypersensitivity syndrome. Indian J Dermatol Venereol Leprol. 2011;77:7–15.
  • Del Pozzo-Magaña BR, Rieder MJ, Garcia-Bournissen F, Lazo-Langner A. Drug reaction with eosinophilia and systemic symptoms (DRESS): a tertiary care centre retrospective study. Br J Clin Pharmacol. 2022;88(9):4134–4141. doi:10.1111/bcp.15354
  • De A, Rajagopalan M, Sarda A, Das S, Biswas P. Drug reaction with Eosinophilia and systemic symptoms: an update and review of recent literature. Indian J Dermatol. 2018;63(1):30–40. PMC5838752. doi:10.4103/ijd.IJD_582_17
  • Scherer K, Brockow K, Aberer W, et al. Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the drug allergy interest group. Allergy. 2013;68(7):844–852. doi:10.1111/all.12161
  • Pandey B, Shrestha K, Lewis J, Hawksworth RA, Walker SL. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. Trop Doct. 2007;37(3):162–163. doi:10.1258/004947507781524700
  • Phillips J, Henderson AC. Hemolytic anemia: evaluation and differential diagnosis. Am Fam Physician. 2018;98(6):354–361.
  • Karonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Lancet. 1996;348(9019):17–24. doi:10.1016/S0140-6736(96)02166-6
  • Brockhaus L, Schmid Y, Rast AC, Rätz Bravo AE, Hofmeier KS, Leuppi-Taegtmeyer AB. Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports. BMC Pharmacol Toxicol. 2019;20(1):9. doi:10.1186/s40360-019-0289-7
  • Jung HY, Park S, Shin B, et al. Prevalence and clinical features of drug reactions with Eosinophilia and systemic symptoms syndrome caused by antituberculosis drugs: a Retrospective Cohort Study. Allergy Asthma Immunol Res. 2019;11(1):90–103. doi:10.4168/aair.2019.11.1.90
  • Liu H, Wang Z, Bao F, et al. Evaluation of prospective HLA-B* 13: 01 screening to prevent dapsone hypersensitivity syndrome in patients with leprosy. JAMA Dermatol. 2019;155(6):666–672. doi:10.1001/jamadermatol.2018.5360
  • Zhang F-R, Liu H, Irwanto A, et al. HLA-B* 13: 01 and the dapsone hypersensitivity syndrome. N Engl J Med. 2013;369(17):1620–1628. doi:10.1056/NEJMoa1213096

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.